Concepedia

Author

Jean Dallongeville

Institut Pasteur de Lille

Also Known As

Adeline Rollin Sillaire, Claudio Borghi, D. Arveiler, Dallongeville, J., Dallongeville, J. (Jean), Dallongeville, Jean, Etiévant, Patrick, H. Bueno, J DALLONGEVILLE, J Dallongeville

363

Publications

17.7K

Citations

58

H-Index

154

Concepts

All Affiliations

Institut Pasteur de LilleInsermUniversité de LilleCentre Hospitalier Universitaire de LilleUniversité Fédérale de Toulouse Midi-Pyrénées
JD

About

Jean Dallongeville is an author at Institut Pasteur de Lille specializing in medicine, public health, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

33

63

6K

2

Public Health

28

50

4.5K

3

Health Sciences

14

15

1.3K

4

Natural Sciences

2

2

305

5

Engineering

1

1

24

Jean Dallongeville

×

142

Publications

12.4K

Citations

57

H-Index

YearCitations

Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)

Ian Graham, Dan Atar, Knut Borch‐Johnsen,

European Journal of Cardiovascular Prevention & Rehabilitation

2007

1.7K

EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE

Daniel De Backer, K. Borch‐Johnsen, Carlos Brotons,

Rational Pharmacotherapy in Cardiology

2005

1.3K

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.

Bart Staels, Ngoc Vu‐Dac, V. A. Kosykh,

Journal of Clinical Investigation

1995

408

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.

Ngoc Vu‐Dac, Kristina Schoonjans, V. P. Kosykh,

Journal of Clinical Investigation

1995

397

Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study

José R. Banegas, Esther López‐García, Jean Dallongeville,

European Heart Journal

2011

354

Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element

Thierry Claudel, Ekkehard Sturm, Hélène Duez,

Journal of Clinical Investigation

2002

288

Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)

Ian D. Graham, Dan Atar, Knut Borch‐Johnsen,

European Journal of Cardiovascular Prevention & Rehabilitation

2007

281

European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

Guy De Backer, Ettore Ambrosioni, Knut Broch-Johnsen,

European Journal of Cardiovascular Prevention & Rehabilitation

2003

275

Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element

Thierry Claudel, Ekkehard Sturm, Hélène Duez,

Journal of Clinical Investigation

2002

273

An International Model to Predict Recurrent Cardiovascular Disease

Peter W.F. Wilson, Ralph B. D’Agostino, Deepak L. Bhatt,

The American Journal of Medicine

2012

239

Page 1